29.02.2012 • NewsHCS GroupDow Haltermannsales and profits

Haltermann Reports Postive First 6 Months

Six months after Haltermann, previously a subsidiary of Dow, became an independent company, Haltermann's CEO, Dr. Uwe Nickel has expressed satisfaction with how business is developing. Dr Nickel is optimistic about the future. Since the company was spun-off in July 2011, Haltermann, which specializes in high-purity refinery chemicals, increased its revenue by 20% over the previous year. In a press release, the company said it has been able to pass on the high price increase of raw materials. Nickel is cautious about 2012 expectations.

"We will only have clarity about the market development after the first three to five months of 2012," he said.

 

 

 

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.